Concepedia

Jolien M.R. Van der Meer

JM

Statistics

Publications

5

Citations

214

H-Index

5

Active since

2018

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Radboud Institute for Molecular Life Sciences

University Medical Center

Jolien M.R. Van der Meer is an author at Radboud University Nijmegen specializing in cell transplantation, immune regulation, and t cell immunity.

ORCID

Top concepts

Publications per year

2018–2023

5

Publications

5

Peritoneal NK cells are responsive to IL-15 and percentages are correlated with outcome in advanced ovarian cancer patients

Janneke S. Hoogstad‐van Evert, Ralph J. A. Maas, Jolien M.R. Van der Meer et al. · Oncotarget · 2018 · 70 citations · Full text

TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer

Ralph J. A. Maas, Janneke S. Hoogstad‐van Evert, Jolien M.R. Van der Meer et al. · OncoImmunology · 2020 · 65 citations · Full text

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells

Jolien M.R. Van der Meer, Ralph J. A. Maas, Karolin Guldevall et al. · Cancer Immunology Immunotherapy · 2020 · 43 citations · Full text

, , +21

CD34 <sup>+</sup> progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg <sup>null</sup> mice

Jolien M.R. Van der Meer, Paul K.J.D. de Jonge, Anniek B. van der Waart et al. · OncoImmunology · 2021 · 19 citations · Full text

Good manufacturing practice production of CD34+ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia

Paul K.J.D. de Jonge, P.M.M. van Hauten, L. D. Janssen et al. · Cancer Immunology Immunotherapy · 2023 · 17 citations · Full text

1–5 of 5